Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHR
2901
CALL
Braemar Hotels & Resorts
BHR
$142M
| $2.96M | ﹤0.01% |
212,201
+184,224
| +658% | +$2.74M |
|
|
AXDX
2902
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $2.96M | ﹤0.01% |
10,860
+4,100
| +61% | +$907K |
|
2903
PUT
Manulife Financial
MFC
$71.6B
| $2.96M | ﹤0.01% |
209,800
+72,600
| +53% | +$987K |
|
|
NRF
2904
CALL
DELISTED
NorthStar Realty Finance Corp.
NRF
| $2.96M | ﹤0.01% |
224,700
-26,500
| -11% | -$342K |
|
2905
CALL
Viasat
VSAT
$10B
| $2.96M | ﹤0.01% |
39,600
+20,700
| +110% | +$1.53M |
|
|
GOV
2906
PUT
DELISTED
Government Properties Income Trust
GOV
| $2.95M | ﹤0.01% |
130,600
+105,400
| +418% | +$2.47M |
|
2907
PUT
Designer Brands
DBI
$278M
| $2.95M | ﹤0.01% |
144,200
+91,400
| +173% | +$2.14M |
|
2908
Curtiss-Wright
CW
$22.4B
| $2.95M | ﹤0.01% |
32,400
-19,600
| -38% | -$1.72M |
|
2909
CALL
HealthEquity
HQY
$7.72B
| $2.95M | ﹤0.01% |
78,000
-36,800
| -32% | -$1.17M |
|
|
PRXL
2910
CALL
DELISTED
Parexel International Corp
PRXL
| $2.95M | ﹤0.01% |
42,500
+19,500
| +85% | +$1.32M |
|
|
MSCC
2911
CALL
DELISTED
Microsemi Corp
MSCC
| $2.95M | ﹤0.01% |
70,200
+31,900
| +83% | +$1.22M |
|
2912
Sysco
SYY
$39.5B
| $2.94M | ﹤0.01% |
60,000
-25,000
| -29% | -$1.28M |
|
|
MASI
2913
DELISTED
Masimo
MASI
| $2.94M | ﹤0.01% |
49,428
-572
| -1% | -$32.3K |
|
2914
PUT
Pan American Silver
PAAS
$22.8B
| $2.94M | ﹤0.01% |
166,800
-131,100
| -44% | -$2.45M |
|
2915
PUT
ProShares UltraShort Yen
YCS
$30.1M
| $2.94M | ﹤0.01% |
193,600
-70,400
| -27% | -$1.09M |
|
2916
PUT
Hyatt Hotels
H
$16.3B
| $2.93M | ﹤0.01% |
59,600
+6,000
| +11% | +$309K |
|
2917
PUT
Ameriprise Financial
AMP
$49.1B
| $2.93M | ﹤0.01% |
29,400
-6,100
| -17% | -$591K |
|
2918
CALL
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $2.93M | ﹤0.01% |
78,400
+54,700
| +231% | +$2.01M |
|
|
CA
2919
DELISTED
CA, Inc.
CA
| $2.93M | ﹤0.01% |
+88,624
| New | +$2.99M |
|
|
NUAN
2920
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $2.93M | ﹤0.01% |
233,426
-175,098
| -43% | -$2.29M |
|
|
CRAY
2921
PUT
DELISTED
Cray, Inc.
CRAY
| $2.93M | ﹤0.01% |
124,400
+87,300
| +235% | +$2.23M |
|
2922
iShares California Muni Bond ETF
CMF
$4.63B
| $2.93M | ﹤0.01% |
+48,486
| New | +$2.94M |
|
|
SHLX
2923
CALL
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $2.92M | ﹤0.01% |
91,100
-83,100
| -48% | -$2.62M |
|
2924
World Kinect Corp
WKC
$1.83B
| $2.92M | ﹤0.01% |
63,100
-38,700
| -38% | -$1.78M |
|
|
CYNO
2925
CALL
DELISTED
Cynosure, Inc. Class A
CYNO
| $2.92M | ﹤0.01% |
57,300
+31,300
| +120% | +$1.63M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.